Lankenau Heart Group physician practices honored by American Heart Association
Lankenau Heart Group physician practices, part of Main Line Health’s Lankenau Heart Institute, have been recognized by the American Heart Association (AHA) for their commitment to managing heart disease risk by controlling risk factors like high cholesterol and diabetes.
Both awards are a testament to Lankenau Heart Institute’s commitment to the prevention, diagnosis, treatment and management of cardiovascular disease.
To effectively manage cholesterol among patients, Lankenau Heart Group physicians prescribed statins for adult patients who:
- Had a diagnosis of clinical atherosclerotic cardiovascular disease
- Had been previously diagnosed or had a family history of high cholesterol
- Were between ages 40-75 with Type 1 or Type 2 diabetes and an LDL of 70-189 mg/dL
Additionally, Lankenau Heart Group at Newtown Square received the AHA’s Target: Type 2 Diabetes Gold Award for implementing quality improvement measures to address the relationship between diabetes and cardiovascular disease in the outpatient setting.
“These well-deserved awards recognize our Lankenau Heart Group physician practices for their ongoing commitment to keeping our patients well by not only following proven guidelines that reduce the onset or recurrence of heart and vascular disease, but also by providing education and guidance to help inform healthy decisions. At Lankenau Heart Institute, we offer advanced surgical and interventional care for complex cardiovascular issues when they arise, but the goal is always to be able to offer early, preventative approaches that reduce the need for those hospitalizations. These awards are a testament to the excellent care being offered at our practices, and we couldn’t be more proud to be receiving them,” says William Gray, MD, System Chief of Cardiovascular Disease at Main Line Health.
High cholesterol and diabetes are two of the most common risk factors for heart disease. Nearly one in three American adults have high LDL or “bad” cholesterol and need personalized treatment while every 80 seconds, an adult with diabetes in the U.S. is hospitalized for heart disease.
Lankenau Heart Institute offers the full continuum of cardiovascular care: prevention, diagnosis, imaging, treatment, cardiac rehabilitation and disease management at its hospitals and 16 Lankenau Heart Group practices across the region.
About Lankenau Heart Institute
Lankenau Heart Institute is Main Line Health’s premier comprehensive cardiovascular program, bringing together cardiologists, cardiovascular surgeons and advanced practice providers across the System’s four acute care hospitals: Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital. Through a coordinated approach, the Institute offers a full continuum of high-quality cardiovascular care — from prevention and diagnostics to clinical trials, advanced treatments and rehabilitation — with a commitment to excellence in outcomes and patient experience.
A nationally recognized leader in innovation and exceptional clinical outcomes, Lankenau Heart Institute is at the forefront of minimally invasive and transcatheter procedures for coronary revascularization, valve repair and replacement, complex aortic surgery and the treatment of advanced heart failure and arrhythmias. Its pioneering work in robotic-assisted and beating-heart techniques and minimally invasive and robotic valve repair continues to shape the future of cardiovascular care. With a robust and influential presence in national clinical trials, its physicians regularly participate in groundbreaking research focused on new therapies, technologies and procedures, primarily through less invasive approaches.
About Main Line Health
Main Line Health® is a not-for-profit health system serving the greater Philadelphia region. The System comprises five hospitals, seven health centers, more than 160 outpatient and physician practice locations, over 14,500 employees and more than 2,200 employed and independent physicians and advanced practice providers.
Founded in 1985, Main Line Health includes four of the region’s most respected acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as Bryn Mawr Rehab Hospital, one of the nation’s premier facilities for rehabilitative medicine. The System also includes Mirmont Treatment Center, which provides treatment and support for substance use disorders; Main Line Health HomeCare & Hospice; Main Line HealthCare, its employed multispecialty physician network; Lankenau Institute for Medical Research, a leading biomedical research organization; and Main Line Health Centers offering primary and specialty care, lab, radiology and other outpatient services in Broomall, Collegeville, Concordville, Devon, Exton, King of Prussia and Newtown Square.
Main Line Health brings together physicians, advanced practice providers, nurses, researchers and other healthcare professionals across a broad network of inpatient, outpatient, home-based and community-based services. Through this integrated approach, the System delivers high-quality, comprehensive care across the continuum — from primary care and preventive services to complex specialty, surgical, trauma, emergency, rehabilitative, behavioral health, home care and hospice services — with a focus on making care accessible in the communities where people live and work.
Main Line Health also collaborates with leading clinical partners to expand access to specialized care. Through its affiliation with Children's Hospital of Philadelphia, pediatric care is provided at select Main Line Health locations, including neonatal intensive care units at its acute care hospitals and Bryn Mawr Hospital’s Inpatient Pediatric Unit and Emergency Department. Jefferson Health neurosurgeons and neurointerventionalists also provide 24/7 specialized care, including neurointervention and lifesaving stroke care.
Contact
Phil Ellingsworth, Jr.Director, Communications
Office: 484.580.1182
EllingsworthPh@mlhs.org